New high-throughput, no-wash assays contribute to the development, manufacture and quality control of safer, more effective biotherapeutics
Cantex also plans to initiate Phase 2 clinical trials exploring the therapeutic effect of azeliragon in pancreatic and breast cancers.
Bangladesh, Indonesia, Pakistan, Serbia and Vietnam to receive mRNA technology from the technology transfer hub
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Company to manufacture drug substance for clinical supply of HaemaLogiX’s lead multiple myeloma drug candidate, KappaMab, at its new state-of-the-art facility in Guangzhou, China
Their strong recommendation is based on moderate certainty evidence that it improves survival and reduces the need for ventilation
In addition to its favourable activity profile, IBIO123 is formulated for administration by inhalation providing an efficient, rapid and non-invasive delivery method into the lungs via the respiratory tract
The investment in Yapan Bio allows Piramal Pharma Solutions to broaden its service offerings in the fast-growing biologics CDMO space
Evusheld is a combination of two long-acting monoclonal antibodies and is the only antibody therapy authorised in the US to prevent Covid-19
The Institute of Pulmonology Medical Research & Development organised a symposium on early management of Covid-19
Subscribe To Our Newsletter & Stay Updated
